Current and emerging treatment strategies for breast cancer-induced bone loss. - Wikidata - awgldk - TriplyDB

Current and emerging treatment strategies for breast cancer-induced bone loss.

Current and emerging treatment strategies for breast cancer-induced bone loss.

http://www.wikidata.org/entity/Q37355790

about

Current and emerging treatment strategies for breast cancer-induced bone loss.

http://www.wikidata.org/entity/Q37355790

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current and emerging treatment strategies for breast cancer-induced bone loss.

@en

Current and emerging treatment strategies for breast cancer-induced bone loss.

@nl

type

label

Current and emerging treatment strategies for breast cancer-induced bone loss.

@en

Current and emerging treatment strategies for breast cancer-induced bone loss.

@nl

prefLabel

Current and emerging treatment strategies for breast cancer-induced bone loss.

@en

Current and emerging treatment strategies for breast cancer-induced bone loss.

@nl

P1433

Q37355790-67863678-EC97-4789-9286-32B8878AFEC0

P1476

Q37355790-B561A2D4-1E46-410A-A8B3-ED3D9477509D

P2093

Q37355790-9CC0292D-E62B-4D1B-AB9A-ACF4FA0D1798

P2860

Q37355790-02F8F7C4-4A55-4D29-9605-47F23F753885

Q37355790-11387788-127C-4BD1-918A-E55453DE0E7F

Q37355790-17FB6938-37E6-4169-A066-2DDBB815FFFF

Q37355790-19B72154-B104-46A9-8DB8-1135A107BB38

Q37355790-23A4CD93-9E7B-418E-8190-980AF25C2FED

Q37355790-2856CD30-B332-4473-8556-D419176C066F

Q37355790-3D30F3A6-FDE4-49E9-9F06-7BB9D0A6EA2B

Q37355790-40ACF6F0-9D41-4599-9199-636131CC965C

Q37355790-4F0765BC-A80D-415B-B854-FAD170E63922

Q37355790-5AE391BC-896B-4D62-9BB6-C38AFB1B3C0A

P304

Q37355790-50796ED6-21E1-44D4-925B-220D747F81A2

P31

Q37355790-5F566145-23E4-4508-9565-366477DEA448

P356

Q37355790-DCE46A8F-5525-420A-A784-2D261D68830F

P478

Q37355790-40191799-90AC-4250-BCA1-D317F088D3D7

P577

Q37355790-D6EE7AB2-BD2F-4BDD-AC29-E8622B70A808

P698

Q37355790-29B1CFFE-FF71-4682-A938-B3745D10C351

P932

Q37355790-458BA1F1-6570-4B49-AE6D-3DF122F70CEE

P356

P1433

Breast Cancer: Targets and Therapy

P1476

Current and emerging treatment strategies for breast cancer-induced bone loss.

@en

P2093

Stephanie L Hines

http://www.w3.org/2001/XMLSchema#string

P2860

Denosumab in postmenopausal women with low bone mineral density

Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer

A high incidence of vertebral fracture in women with breast cancer.

Influence of RANKL inhibition on immune system in the treatment of bone diseases.

Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer.

P304

71-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BCTT.S9911

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24367168

http://www.w3.org/2001/XMLSchema#string

P932

3846568

http://www.w3.org/2001/XMLSchema#string